Vitamin D deficiency is associated with cortical bone loss and fractures in the elderly

in European Journal of Endocrinology
Correspondence should be addressed to F P Paranhos-Neto; Email: francisco.paranhos@hotmail.com
Restricted access

Introduction

The role of vitamin D on bone microarchitecture and fragility is not clear.

Objective

To investigate whether vitamin D deficiency (25(OH)D <20 ng/mL) increases cortical bone loss and the severity of fractures.

Design

Cross-sectional study of 287 elderly women with at least one prevalent low-impact fracture.

Methods

Biochemistry, X-rays to identify vertebral fractures (VFs) and to confirm non-vertebral fractures (NonVFs), and high-resolution peripheral quantitative computed tomography (HR-pQCT) to evaluate bone microstructure.

Results

Serum 25(OH)D levels were associated with body mass index (BMI: r = −0.161, P = 0.006), PTH (r = −0.165; P = 0.005), CTX (r = −0.119; P = 0.043) and vBMD at cortical bone (Dcomp: r = 0.132; P = 0.033) and entire bone (D100: r = 0.162 P = 0.009) at the distal radius, but not at the tibia. Age and PTH levels were potential confounding variables, but in the multiple linear regressions only BMI (95% CI: 0.11–4.16; P < 0.01), 25(OH)D (95% CI: −0.007 to 1.70; P = 0.05) and CTX (95% CI: −149.04 to 21.80; P < 0.01) predicted Dcomp, while BMI (95% CI: 1.13–4.18; P < 0.01) and 25(OH)D (95% CI: 0.24–1.52; P < 0.01) predicted D100. NonVFs predominated in patients with 25(OH)D <20 ng/mL (P = 0.013). Logistic regression analysis showed a decrease in the likelihood of presenting grade 2–3 VFs/NonVFs for every increase in 25(OH)D (OR = 0.962, 95% CI: 0.940–0.984; P = 0.001), BMI (OR = 0.932, 95% CI: 0.885–0.981; P = 0.007) and D100 at radius (OR = 0.994, 95% CI: 0.990–0.998; P = 0.005).

Conclusion

In elderly patients with prevalent fractures, vitamin D deficiency was associated with cortical bone loss and severity of fractures.

Downloadable materials

  • Supplementary Table 1 - Comparisons of biochemical and HR-pQCT-derived bone parameters in vitamin D deficient, insufficient and sufficient patients (subgroups I, II and III, respectively).

 

     European Society of Endocrinology

Related Articles

Article Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 44 44 44
Full Text Views 6 6 6
PDF Downloads 4 4 4

Altmetrics

Figures

  • View in gallery

    Flowchart of the selection strategy and inclusion/exclusion criteria in the study.

PubMed

Google Scholar